MLL Gene Rearrangement in Acute Myelogenous Leukemia After Exposure to Tegafur/Uracil

スポンサーリンク

概要

• 論文の詳細を見る

著者

• Kida Hiroshi

  国立病院機構金沢医療センター

• FUKUSHIMA Toshihiro

  Internal Medicine, National Kanazawa Hospital

• Noto Yutaka

  Internal Medicine National Kanazawa Hospital

• Yoshio Nobuyuki

  Internal Medicine National Kanazawa Hospital

• Fukushima Toshihiro

  Internal Medicine National Kanazawa Hospital

• Kida Hiroshi

  Internal Medicine National Kanazawa Hospital

関連論文

• A Pharmacokinetic Study of Idarubicin in Japanese Patients With Malignant Lymphoma: Relationship With Leukocytopenia and Neutropenia
• Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia.
• Long-term follow-up the clinical efficacy of chemotherapy for acute myeloid leukemia at a single institute
• Monitoring of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in 1-beta-D-arabinofuranosylcytosine therapy at low and conventional doses.
• Successful treatment of cytomegalovirus retinitis in a patient with malignant lymphoma: a case report and review of the literature
• MLL Gene Rearrangement in Acute Myelogenous Leukemia After Exposure to Tegafur/Uracil

スポンサーリンク